GeneBioTech (Korea) Today
| 086060 Stock | KRW 3,350 10.00 0.30% |
Performance0 of 100
| Odds Of DistressLess than 9
|
GeneBioTech is trading at 3350.00 as of the 17th of December 2024, a 0.30 percent increase since the beginning of the trading day. The stock's open price was 3340.0. GeneBioTech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Genebiotech Co., Ltd., a specialized fermentation company, researches, develops, produces, and sells biological resources for use in animal resources, agriculture, food, medicine, etc. The company was founded in 1984 and is headquartered in Gongju, South Korea. The company has 8.37 M outstanding shares. More on GeneBioTech Co
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
GeneBioTech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. GeneBioTech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding GeneBioTech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Chan Lee |
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
GeneBioTech Co (086060) is traded on KOSDAQ in Korea and employs 37 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 35.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GeneBioTech's market, we take the total number of its shares issued and multiply it by GeneBioTech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GeneBioTech operates under Biotechnology sector and is part of Health Care industry. The entity has 8.37 M outstanding shares.
GeneBioTech Co has accumulated about 7.43 B in cash with (2.84 B) of positive cash flow from operations.
Check GeneBioTech Probability Of Bankruptcy
Ownership AllocationThe market capitalization of GeneBioTech is W35.37 Billion. GeneBioTech secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check GeneBioTech Ownership Details
GeneBioTech Risk Profiles
Although GeneBioTech's alpha and beta are two of the key measurements used to evaluate GeneBioTech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.27 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.91 | |||
| Risk Adjusted Performance | (0.01) |
GeneBioTech Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GeneBioTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Other Information on Investing in GeneBioTech Stock
GeneBioTech financial ratios help investors to determine whether GeneBioTech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GeneBioTech with respect to the benefits of owning GeneBioTech security.